Insider · CIK 0001767084
Scott Juda
Files at INMB (Inmune Bio, Inc.). First filing Nov 13, 2023, latest Nov 13, 2023.
In brief
Scott Juda files SEC Form 4 as director at INMB (Inmune Bio, Inc.). Since Nov 13, 2023, Scott Juda has reported 1 open-market buy worth $49k and 0 open-market sells worth $0, the latest filed on Nov 13, 2023.
A track record needs three past buys with six months of prices behind them; Scott Juda has 0, so none is measured yet.
The newest scored trade: bought $49k of INMB on Nov 10, 2023, filed Nov 13, 2023, scored 28 (weak).
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | INMB Inmune Bio, Inc. | MOption exercise Common Stock | +14,801 | $1.40 | $21k | 86,404 | Jul 7, 2026 |
| Jul 2, 2026 | INMB Inmune Bio, Inc. | XIn-the-money exercise Common Stock Purchase Warrantderivative | -14,801 | $0.13 | $1,850 | 14,802 | Jul 7, 2026 |
| Dec 1, 2025 | INMB Inmune Bio, Inc. | AGrant or award Option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Dec 2, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -108,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +108,000 | - | - | 108,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -108,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +108,000 | - | - | 108,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -15,975 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,975 | - | - | 15,975 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -19,025 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,025 | - | - | 19,025 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -35,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -35,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -32,500 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +32,500 | - | - | 32,500 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -12,500 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,500 | - | - | 12,500 | Nov 18, 2025 |
| Dec 5, 2024 | INMB Inmune Bio, Inc. | AGrant or award Option (right to buy)derivative | +32,500 | $0.00 | $0 | 32,500 | Dec 9, 2024 |
| Nov 10, 2023 | INMB Inmune Bio, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +7,000 | $6.95 | $49k | 37,000 | Nov 13, 2023 |
Questions about Scott Juda
Answered from the filings on this page, as of the latest one.
Is Scott Juda buying or selling?
Not in the last 12 months. Scott Juda's latest open-market trade on SEC Form 4 was bought $49k of INMB on Nov 10, 2023.
How did Scott Juda's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Scott Juda has 0.
Where does Scott Juda file Form 4?
Scott Juda has filed Form 4 at INMB (Inmune Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.